China's Global Times Says China's Coronavirus Vaccine Trial Has 'been found to be safe, well-tolerated, and able to generate an immune response against SARS-COV-2 in humans, according to a study published online on Friday by medical journal The Lancet.'
Benzinga Newsdesk